untitled
|
|
|
- ゆゆこ かいじ
- 5 years ago
- Views:
Transcription
1 ver. 3.3JT
2 EVENING PRIMROSE EXTRACT 1 - PMS 1
3 2 1 4 Oenothera laciniata Oenothera striata Oenothera biennis Oenothera erythrosepala
4 3 PGGPAC 2. 3
5 4 ESR /g 4
6 3 1 Helicobacter pylori H.pylori Osaki et.al., J Med Microbiol.2002 NH PPI 2 MACH 1 study 85% % 8.8% 2.6% 1.4% 3.9% 5
7 4 3 SOD VacA PAI Type CagA LPS NapA IL-6 IL-8 DNA
8 4 1 MIC 64µg/ml ATCC43503 ATCC43504 ATCC43579 ATCC49503 NCTC1163 TK1003 TK1008 TK1021 TK1022 TK1023 TK1025 TK1029 TK1030 TK1036 TK1042 TK1402 KR2001 KR 2002 KR 2003 KR 2005 KR 2007 KR 2009 KR 2067 KR >128 > , 4. µ /ml
9 PGG 64 PGG PAC 64 >128 > µ /ml 5. 6 Y X h0µg/ml µg/ml µg/ml Log of CFU/ml µg/ml 512µg/ml 256µg/ml 128µg/ml 64µg/ml 32µg/ml h 6. H.pylori H. pylori TK BHI (512,256,128,64,32,0µg/ml).0,2,4,240.1ml. 8
10 2 ph IC µg/ml 100 (%) (µg/ml) µg/ml
11 8 Y X µg/ml negative control(mkn45 cell only) positive control(0%) 64µg/ml 32µg/ml 16µg/ml Osaki et.al.,j Med Microbiol Fluorescence intensity 8. H. pylori TK1402( TK1402 ).7 BHI 5 10 CFU/mlPKH-2 (64,32,16µg/ml) TK1402 ( MKN45 ) 30 TK1402 MKN45 1. H. pylori MKN45 (FCM). 1. H.pylori µg/ml (98.10) (98.18) (82.45) (0). MKN45 A MKN45 onlya MKN45 T 1 T A A )( ) 10
12 4 MGS/Sea,, TK1402 ( 9 CFU/ml)mg/ml (/,, ) 1 H.pylori 16SrRNA RT PCR(reverse transcription-polymerase chain reaction) H.pylori 9 16S rrna c 5 4 b S rrna a b c d e f 9. 16S rrna RT-PCR () H.pylori 11
13 5 ddy 240mg/kg S.D. Log of CFU/stomach Con mg/kg 10. ddy H. pylori ddy 4,10 8 CFU/ml H.pylori 0.5ml mg kg H.pylori 6 12
14 6 2 ( cont. ) mg/kg ( 500mg/kg ) 1.6 mm) S.D mg/kg cont. 500mg/kg ( istar)( g) ml10mg ml 10 (mm 2 ) Scion Image ml (cont.)5 13
15 7 cont Log of CFU/ml cont. 32 µg/ml 64 µg/ml 128 µg/ml 256 µg/ml 512 µg/ml h
16 UBT PH120mg 5 840mg 4 -PH 2 8 / 13 C 13 CO 2 13 C 13 CO 2 UBT UBT 13 2 UBT ELISA
17 / / / / 15 2 / / / 16
18 ph ph 17. ph ph
19 6. PH mg/WSPH mg/ 7. -PH -WSPH 1.5g 100g 2.0 g 100g 2.2 g 100g 2.6 g 100g 1.6 g 100g 0.1 g 100g 1.2 g 100g 6.4 g 100g 93.2 g 100g 86.1 g 100g 0.3 g 100g 2.8 g 100g 4.8mg 100g 29.9mg 100g 396kcal 100g 356 kcal 100g -P WSP -P WSP
20 8. 1 BHC 0.02ppm DDT 0.02ppm 0.01ppm 0.01ppm 0.01ppm 0.05ppm 0.05ppm 0.05ppm SD mg/kg % % (LD50) 5000 mg/kg 3 (CHL/IU) µg/ml µg/ml µg/ml µg/ml 5 CHL/IU 19
21 4 Ames Salmonella typhimurium( ) Esherichia coli() WP2uvrA Ames mg/kg mg PH -WSPH 5kg 20
22
23 1. Folin-Denis 4. H. pylori (Brucella Agar) (O 2 5,CO 2 10, 2 85 ) 10 (FCS) (Brucella Broth) FCS H.pylori 37,O 2 5,CO 2 10, H.pylori H. pylori TK (Brain Heart Infusion BHI) (512, 256,128,64,32,0µg/ml).0,2,4,24 0.1ml /ml 50µ mm 100 mm 300µ µ mg 500 ml 2.5 ml 300 ml ml 500 ml 2.5 ml nm 8. H. pylori TK1402 ( CFU/ml) PKH-2 (MKN45 ) (FCM) 22
24 9. 16SrRNA RT-PCR H.pylori MGS/Sea,9, H.pylori H. pylori TK1402 ( CFU/ )mg/ml (/,, ) 1 H.pylori 16SrRNA RT PCR(reverse transcription-polymerase chain reaction) H.pylori 10. ddy H. pylori ddy 4,10 8 CFU/ml H.pylori 0.5ml/ ,30,60,120,240mg/kg H.pylori ( istar)( g) ml 10mg ml 10 (mm 2 ) Scion Image ml (con) NBRC NO Lactobacillus brevis MRS-broth 24h 0.1ml BCP 48h / -PH120mg 5 840mg 4 -PH 2 8 / 23
25 Oenothera biennis Folin-Denis g ) 1 10 ppm 2 1 ppm g g BGLB
26 Oenothera biennis Folin-Denis g ) 1 10 ppm 2 1 ppm ( ) g g BGLB
27 TEL(0586) ( ) FAX(0586) URL/ info@oryza.co.jp F TEL (03) FAX (03) tokyo@oryza.co.jp
28 27
untitled
ORYZA POLYAMINE ORYZA POLYAMINE -P -PC -LC 1. Ver.1.0 MM ver. 1.0MM 1) Roseeuw D.I. et al., Epidermal keratinocytes actively maintain their intracellular polyamine levels. Cell Tissue Kinet. 16, 493-504
19世紀の末よりヒトや動物の胃にスピロヘーター様細菌が存在するという報告がなされていたが、消化性潰瘍や胃炎との関連を論じられることも少なく、胃は無菌臓器という概念が浸透していた
Helicobacter pylori 19 J. Warren B. Marshall 1984 7 Marshall 10 Warren Marshall 1984 Campylobacter pyloridis pylorus C. pylori Campylobacter 1989 Goodwin Helicobacter H. pylori Herical: Pylori: Helicobacter
ver5.1 HS 1. ALPHA LIPOIC ACID () S S COOH HS 1. α - SH COOH - ( 1) CoA -( 2)- - --P80 (--WSP8-L1-WSPC8 -LC1) - 1
ORYZA OIL & FAT CHEMICAL CO., LTD. ALPHA LIPOIC ACID --P () --P80 () --WSP8 () --L1 () --PC () --PC80 () --WSPC8 () --LC1 () ver. 5.1HS ver5.1 HS 1. ALPHA LIPOIC ACID 16 3 31 0331009 - () 19 5 24 0524001
untitled
ORYZA CERAMIDE -PTPCDP8TP20CD -WSPWSP8 -LL0.8 -PCPC8PC20 -WSPCWSPC8 -LCLC0.8 Ver.13.0HS ORYZA CERAMIDE Ver.13.0HS 1. 2. 20 NMR 4 ( 1) 1 Ver.13.0HS HO CH 2 OH O O OH OH OH C CH CH H 2 NH C O R C H C H (CH
<4D F736F F D208C8E8CA D838A838A815B C E342E646F63>
ORYZA OIL & FAT CHEMICAL CO., LTD. 月見草エキス EVENING PRIMROSE EXTRACT ピロリ菌感染予防作用 月見草エキス -PH ( 粉末 食品用途 ) 月見草エキス -WSPH ( 水溶性粉末 食品用途 ) Ver. ver. 3.4 3.3JT JT ピロリ菌感染予防食品素材 月見草エキス EVENING PRIMROSE EXTRACT 1. はじめに
untitled
ver.3.4 JT Actinidia chinensis Planch. 20 KIWI 1966 1970 4 t 1 46 810 5- Propionibacterium acnes - 1. 1 ver.3.4 JT - 2 quercitrin kaempferol 3-O-rhamnoside 3 1) quercitrin advanced glycation end product
untitled
RYZA IL & FAT CHEMICAL C., LTD. SAKURA EXTRACT Ver.1.4MK Ver. 1.4MK 1) 1300 1929 1 Ver. 1.4MK Sakura 1-caffeoyl---D-glucopyranoside quercetin 3---D-glucopyranoside 1) :, 4, 11-22 (1995). 2 Ver. 1.4MK 3
untitled
ORYZA OIL & FAT CHEMICAL CO., LTD. WHITE JELLY FUNGUS EXTRACT -P () Ver. 1.3SJ Ver. 1.3SJ 1. 3000 ph 1 Ver. 1.3SJ 1. 1 2. 3 2-1. 2-2. 2-3. 2-4. SOD 3. 7 3-1. in vitro 3-2. in vivo 3-3. in vivo 3-4. in
untitled
er. 3.0SJ ver.3.0 SJ 3 2 1 ver.3.0 SJ 900 1200 () 400 2 ver.3.0 SJ OH OMe OMe O O O MeO O MeO OMe O O OMe O OMe OMe O O MeO O O H O O MeO OMe O H O OH OMe O CH 2 HO O O O O CH 3 OH HO OH OH HO OH O 1 3
gtf Wnt5a-Ror2 IL-8 in vitro Ozony Tron P. gingivalis SOD ELISA Location of main occluding areas and masticatory ability in patients with reduced occlusal support 12-Methacryloyloxydodecylpyridinium bromide
CSR報告書2005 (和文)
A 250 200 150 100 50 0 25,000 20,000 15,000 10,000 5,000 0 1,000 800 600 400 200 0 168 14 14 27 54 60 2000 16,975 1,314 1,207 8,977 5,477 2000 698 112 115 292 178 2000 223 24 28
ブック 1.indb
21 1211 27 11 27 12 16 20 11 27 10 20 28 29 30 12 10 11 12 30 13 30 14 10 30 15 11 16 12 17 13 18 14 19 15 20 16 10 21 11 27 106 21 107 108 109 110 21 111 28 112 28 10 113 29 11 11421 30 12 11521 32 13
23 3 11 14 46 9.0 7 10m 40.1m 15,883 2,681 25 4 10 39 40 800 180 24 2425 22 21 24 5 3 21 24 10,899 20,472 13,723 33,007 667 400 79,167 8,620 11,694 10,089 25,131 690 215 56,439 13,614 20,897 15,200 32,213
Microsoft Word - 14_LCMS_アクリルアミド
3--2-3-Iodo-2-propynyl butylcarbamate (IPBC) Carbamic acid, butyl-, 3-iodo-2-propynyl ester Iodocarb CAS 55406-53-6 C 8 H 12 NO 2 I C (g/cm 3 ) (mmhg) log P ow 281.09 (280.9910) 64 68 1.51 1.57 (20 C)
23 3 11 21 24 28 4 31,371 20,822 34,511 21,720 12,278 9,574 7,502 137,778 1 69 83.49% 70 15.55% 0.96 3.61% 40 1.19% 1055 29.65% 28 10 1 2 230,250 43,150 656 138,000 137,832 137,820 121,000 30,000 246,800
L- 11 12 13 15 15 17 17 18 21 23 25 25 27 29 29 30 31 32 32 33 36 36 36 37 37 37 38 39 39 40 42 42 45 46 48 10 48 11 49 11 50 50 50 51 51 51 51 52 52 53 53-54 12 55 55 57 28 3 6 4 8 7 6 100% 3 30 p.5760
まえがき
JAAS0012006 1 -------------------------------------------------------------------------------------------------------- 1 2 --------------------------------------------------------------------------------------------------------
エコリシン点眼液/眼軟膏インタビューフォーム
2011 11 4 871319 1mL 5mg 5mg15 1g 5mg 5mg15 JAN JAN Erythromycin LactobionateJAN Colistin Sodium MethanesulfonateJAN 1970 3 31 1970 8 1 1970 7 20 TEL0120-921-839 06-6321-7056 9 17 https://www.santen.co.jp/medical/admin/a300.jsp
untitled
POLYAMINE -P Ver.1.0 MM ver. 1.0MM POLYAMINE 1. 1) Roseeuw D.I. et al., Epidermal keratinocytes actively maintain their intracellular polyamine levels. Cell Tissue Kinet. 16, 493-504 (1983). 2) Ha.C. et
10 44 1.2 5 4 5 3 6-1 - 1 2 3 4 5 1 2 3 4 5 6 7 8 1 2 3 4 5 6 7 8 9 10 TEL TEL 1 2 TEL FAX TEL FAX TEL FAX 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 1 2 3 4 5 6 ( ) ( ) 2
後期化学_01_濃度
2011 ( ) 1 4 1 100 g g % * 1 100 g 1 g 1 % * 2 (1 g)/(100 g) = 0.01 = 1 % 100 g 100 g 99 g 100 g 1 g 1 % 2.5 g 50 g (2.5 g)/(50 g) = 0.050 = 5.0 % 100 ml g 1 %(w/w) wt% % %(w/v) % / 2 % SI 2 / % 100 ml
小関修正版0705
研 究 課 題 の 概 要 研 究 課 題 名 予 測 微 生 物 学 的 解 析 手 法 を 用 いた 微 生 物 学 的 リスク 評 価 システムの 開 発 主 任 研 究 者 所 属 機 関 小 関 成 樹 ( 独 ) 農 業 食 品 産 業 技 術 総 合 研 究 機 構 食 品 総 合 研 究 所 研 究 成 果 の 概 要 食 品 における 微 生 物 学 的 リスク 評 価 を 効 率
% %
4 8 4 5 414.5 172.1 41.5% 39.8 10% 17 186.4 70.8 4 9 10 11 3 1-1 - 2-2 - - 3 - 10% - 4 - 4060% 5560% 60% 40% 3040 1520 1015 411 7 4 11 610 7080 5060 100 3040 13-5 - 1015 4045 3.04.0 5.06.0 1.52.0 1.01.5
14 12 10 8 6 4 2 0 1 2 3 4 5 6 7 8 9 10 11 12 20 0 0 0 0 0 0 0 0 0 0 0 0 21 0 0 0 0 0 0 0 0 0 0 0 0 22 0 0 0 0 0 0 0 0 0 0 0 0 23 0 0 0 0 0 0 0 0 0 0 0 0 24 0 0 0 0 0 0 0 0 0 0 0 0 25 0 0 0 0 0 0 0 0 0
DNA
1 1 1. 1 2. 2 3. 2 4. 2 2 1. 2 4 5 7 2. 7 3. DNA 8 4. 10 13 Plasmodium (P. falciparum) (P. vivax) (P. malariae) P. ovale 4 40% 200 7 40 48 72 1. - 1 - 2. DNA 3 3. 1) 2) 3) 4) 4. 1 1) - 2 - 2) EDTA 1) 1
ッ ー ー ー() () 2.5 () () 21 1) -1 2) -2 10 m 5 7 23 6 1)2) 3) -1-2 H23.4.25 -15-20 4 75 5 1) -1 (5) (3) (3) (2) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) 1) ( 23 6 8 ) 2) 22 3)
1 2 3 4 5 68g 9g 2g 0.2mg 0.8mg 316kcal 316cal 326kcal 326cal 6 010 3035 15 5355 30 120 20 7 8 9 10 11 () () () 12 1 3 1 5 1 80kcal 20 30 20 30 1 9 7.5 13 7.58.5 910.5 1213.5 11.512.5 14 15 79 23 1520
01 H24事業報告（マハタ高品質種苗生産技術開発）
22 2013 24514 hcg500 IU/kg4554 16 Nested-PCRVNN 2426 0.5 ppm1 90.9 80.9 SAI54.2±0.2 0.5 m 3 211 5,000 95.214,286/2 6 3 57 9 9 010 031 m 2 0.1 ml 30 330 7 mm S S340 2024 6 mm25 37 1040 49X 192X 192X 1 14
2007 1 1 1 7 52 SS 52 1977 30 1955 8 1 1 2 3 1 1
2007 1 1 1 7 52 SS 52 1977 30 1955 8 1 1 2 3 1 1 2 1 3 32 1957 4 12 1 4 31 1956 3 3 11 32 SS 1955 8 3 1957 11 SS SS 24 1949 SS SS 20 1945 20 2 1 1 1 SS 1 2 SS SS 1 SS HI BHI HI HI 1930 Difco HI BHI BHI
Microsoft Word - H18年度生命工学報告書 Astro ver.3
1. Rotavirus Norovirus Adenovirus Astrovirus Sapovirus 5 1) Human Astrovirus HastV 1975 Madeley Cosgrove EM RNA 30nm 5 6 Fig. 1 2) HastV 8 3 5 HastV ELISA Enzyme-Linked ImmunoSorbent Assay RIA Radio immunoassay
参考資料５ 農薬評価書 メタアルデヒド（食品安全委員会資料）
1 3 3 4 5. 6 1. 6 2. 6 3. 6 4. 6 5. 6 6. 6 7. 6. 7 1. 7 2. 8 (1) 8 (2) 9 (3) 9 (4) 10 (5) 10 3. 11 (1) 11 (2) 11 (3) 11 (4) 12 4. 12 (1) 12 (2) 12 (3) 13 5. 13 6. 13 7. 14 8. 15 9. 16 10. 16 (1) 90 16-1
g 51 52
10 12 A 12 C 12 13 13 13 13 16 16 18 18 18 23 23 23 23 23 A 24 25 25 26 28 28 30 32 38 38 41 42 43 10 43 11 45 48 48 120g 51 52 12 3 12 3 350g 120g 1 7 10 260g 90g 90g 30g 9 11 2 gg1 g 1 120g 10 1 12 6
untitled
1 2 1 2002 8 1 2003 11 1 152 2003 11 2 21 53 2003 12 24 4 54 2004 3 22 55 2004 4 9 56 2004 4 15 41 2004 4 15 2004 5 12 2004 5 19 2004 5 20 5 2004 12 16 58 2 2005 1 25 2005 8 23 5962 2005 8 26 2005 9 1
無印良品 2012 自転車 カタログ
26 897895321,000 140cm 76.0cm 16.0kg H LED 3 263 897896025,000 140cm 76.0cm 16.5kg H 3 LED 20 8978984 8978977 19,800 134cm 73.0cm 15.0kg LED 2620 2620 8486656550 5536207483 14512372,100 8279999840 26 77342561,417
14 4 12 10 8 6 3 2 4 2 1 0 0 100200300400500600 100200300400500600700 0 0 100200300400500600 100200300400500600700 (ppm) (ppm) 7 4 6 5 4 3 3 2 2 1 1 0 0 100200300400500600 100200300400500600700 0 0 100200300400500600
untitled
b 0 1PPm 10PPm 100PPm 1000PPm 10000PPm 0.0001% 0.001% 0.01% 0.1% 1% 10% 1PPm 10PPm 100PPm 1000PPm 10000PPm 0.0001% 0.001% 0.01% 0.1% 1% 10% 1PPm 10PPm 100PPm 1000PPm 10000PPm 0.0001% 0.001% 0.01%
(1) (2) (1) (2) (1) Seg (2) Seg (3) Seg (4) Seg (1) (2) (3) ( ) (1) (PCA)...12
(1)...109 (2)...110 (1) 28...111 (2) 28...113 (1) Seg...115 (2) Seg...117 (3) Seg...119 (4) Seg...120 (1)...122 (2)...122 (3) ( )...126 (1) (PCA)...127 (2) Draize...128 (1) Ames...129 2 in vitro...132
32 100 34 51 16,300
32 100 34 51 16,300 - 7 - - 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3 4 5 6 7 8 9 10 11 12 1 1 3 3 5 5 B 6 2 2 4 4 6 10 - - 8 - - - 9 - 20 80 1/3 - - 10 - 0.7 0.9kg 21 147 70-11 - - 50 10cm 50 100 30cm kg 100
untitled
ver. 4.3 HS 14 1,620-6- 1) 2) 1 24% p- 45 1) Schwab D. et al., Hepatic uptake of synthetic chlorogenic acid derivatives by the organic anion transport proteins. J. Pharmacol. Exp. Ther. 296, 91-8 (2001).
20 57
56 20 57 58 59 12 60 ph 61 62 CCA 63 64 ( 1) 700 7.5 86% 54 17 71 2) 700 6.8 86% 50 15 65 3) 600 700 5.7 84% 36 14 50 550 650 4.2 80% 21 6 27 40 500 3.6 78% 16 7 23 3.6 78% 16 7 23 400 700 4.0 78% 18 7
<4D F736F F D20342D D834F DA8E9F5F8AAE97B95F>
H. pylori S1-1 Hp S1-2 H. pylori S1-3 S1-4 75 Helicobacter pylori () S1-5 S1-6 Helicobacter pylori S1-7 H. pylori () S1-8 Helicobacter pylori () : H. pylori S2-1 H. pylori Ferric uptake regulator(fur)
緒言 Listeria monocytogenes ready-to-eat L. monocytogenes ISO - FDA/BAM L. monocytogenes Real-Time PCR DNA PCR SYBR Green ds-dna PCR LAMP Molecular Dete
Rep. Nat l Food Res. Inst No 報 文 3M TM Molecular Detection System を用いた Listeria monocytogenes の 簡易迅速遺伝子検査法の評価 Evaluation of 3M Molecular Detection System for detecting Listeria monocytogenes from food
Ⅱ6.3界面活性剤
6.3 6.3.1 6.3.1 6.3.1.1 (1) (2) a) JIS K 0557 A3 b) JIS K 8891 c) (5g/L) d) (10g/L)JIS K 8576 1g 100mL e) (7+993)JIS K 8951 f) JIS K 8322 g) 0.1g 100mL 30mL 1L 500mL6.8mL 50g 1L h) 1L 500mL6.8mL 50g 1L
PAC PAC PAC
PAC PAC PAC + / 398,145,048 411,745,732 13,600,684 24,250,351 25,778,560 1,528,209 4,241,016 3,942,000 299,016 426,636,415 441,466,292 14,829,877 74,000,000 74,000,000 0 74,000,000 74,000,000 0 178,367,442
untitled
2001 4 26 2003 5 22 2004 7 12 2004 7 15 54 2004 7 21 14 2004 9 16 62 IUPAC4--2--N,N --5-p --1-2 17.07 mg/kg / 100 0.17 mg/kg /ADI cyazofamidiso IUPAC 4--2--N,N- -5-p --1-4-chloro-2-cyano-N,N -dimethyl-5-p
H22応用物理化学演習1_濃度.ppt
1 2 4/12 4/19 4/27 5/10 5/17 5/24 5/31 (20 ) (20 ) (10 ) (50 ) 3 (mole fraction) X = (mol) (mol) i n 1, n 2,, n x N i X i = n i = n i n 1 + n 2 + + n x N 4 (molarity, M) 1 dm 3 ( L) (mol) (mol/l) = 1 L
ニトロトルエン
4-115 116 4-3 2 117 4- g/kg/day mg/kg/day 25 125 30 40 50 100 250 300 ( ) ( ) ( ) ( ) F1 42 10 118 ER 10-11 M 1% 10-11 10-4 M ER 10-4 M 3% 10-11 10-4 M E-screen 10-9 10-4 M AR ( ) 10-6 10-4 M AR ( ) 10-6
HotStarTaq Plus PCRプロトコールとトラブルシューティング( /2008)
February 2008 HotStarTaq Plus PCR HotStarTaq Plus DNA Polymerase HotStarTaq Plus Master Mix Kit PCR HotStarTaq Plus DNA Polymerase PCR 2 HotStarTaq Plus DNA Polymerase Q-Solution PCR 6 HotStarTaq Plus
グリセオール注インタビューフォーム
2006 8 3 873999 871319 IF 1998 9 FAX 1 200mL 300mL 500mL 20g 30g 50g 10g 15g 25g 1.8g 2.7g 4.5g 0.9W/V 200mL500mL 1979 3 13 2004 7 9 1979 5 15 2006 8 300mL 1979 3 13 2004 7 9 1982 11 1 IF 1 MR 63 IF 10
23 3 11 24 21 24 25 4 28 4 2 7 161 2,692 28 12 14 18 18 380 5 3 1 27 21 21 24 10,899 20,472 13,723 33,007 667 400 79,167 8,620 11,694 10,089 25,131 690 215 56,439 13,614 20,897 15,200 32,213 640 416 82,979
AJISAI10-1.PDF
Vol.10,No.1,2001 Jan.2001 Vol.10 No.1 *1 50 10 30 DDT 1980 200 Sarcoptes Scabiei var 0.330.35mm 0.25 Hominis 0.35mm 2/3 1mm 4 1 Vol.10,No1,2001 4 1040 2mm 23 20%KOH 1 13 34 6 2 1417 8 4 1014 45 1025 10
untitled
-1- -2- -4- -5- 20 30 12-6- 8 15 1-7- -8- -9- -10- 40 60-11- -12- 3 4 70 90-13- -14- 2 4 3 5-15- a 3-16- -17- -18- 128 kg 150 200g 100 200g 250 750g 2 1 94 89 89 81 72 390 97 97 83 83 75 97 97 100 86
02.O...r.A..
8 300ha k (m 3 / / ) (0 2 ) 0405 135 270 2 12 0540 162 351 12 24 0810 216 486 500kg 135 459 127 1987 (m 3 / / ) 0566 2266 5947 9 18kg 0057 0425 1019 18 45 0142 0566 1358 45 675 0198 0708 2038 675 945 0283
Microsoft Word - 表紙資料２－４
(1) / 130 g 25 g 520% 170 g 30 g 560% 70 mg 600 mg 11.6% 0 10.5 mg 0% (1) (2) / 50100 g 25 g 200400% 50100 g 30 g 167333% 5001000 mg 600 mg 83167% 1020 mg 10.5 mg 95190% (2) / (1) 45.6 g 30 g 152% (2)
2 7 ( ) µ 30
30 (1) ( ) ( ) ( 18 1 ) 1 2 % 3 ( 5,000 2,500 ) 3,700 1,900 2,100 1,000 50 25 240 120 4 5 175 6 7 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 8 9 11 12 13 14 15 16 16 17 16
2010 1 1 7 2 16 2 2 06in 3 3 錆 錆 06in 4 4 0.1 5 5 HCl Cl NaOH H Cl O 2 H H 2 O NaCl Na OH H 2 O NaCl 2010 6 6 ph3.0 30 mg/l 30 1 O-157 H7 2010 7 7 100 Cl 80 60 40 20 HClO ClO CL ph 10 100,000ppm 12 01
平成26年度 化学物質分析法開発報告書
N,N- N,N-Dimethylacetamide Acethyldimethylamine CAS 127-19-5 C 4 H 9 NO 87.12 ~ 87.14 87.68413 163-165 C 1) - 18.59 C 2) 1 mg/l 25 C 3) 3.3 hpa 2 C 4) log P ow -.77 2).9429 2/4 C 1) 3.1 4) 1.31E - 8 atm-m
<4D F736F F D B BA908593B98AC782AB82E593E082CC88C091538AC7979D82C98AD682B782E992868AD495F18D908F912E646F63>
12 62 1800 14 3 11 14 4 14 4 30 ... 1... 1... 1... 2... 5... 6... 7... 10... 13... 18... 19 21 22 24 27 28 31 32 33... 34... 35... 37 2 1,650mm () H=2,500W=2,000 460m 750m 500m 42.1m 1.15m () 100% 80%
総括研究成果報告書
BILD 1 diethylstilbestrol (DES) estrogen DNA embryonic stem (ES) ES ES A3-1 ES ES Genetic Microsystems DNA 2 3 DNA DNA DNA BILD ES ES ES RNA RNA cdna DNA DNA estrogen MCF-7 RNA DNA ES mrna Differential
ボトックス注用
2018 5 21 2017 1220 5 8 7 1 2 2 9 50 100 22100AMX00488 22100AMX00489 2009 9 2009 9 2009 2 1997 4 2016 6 2018 5 1989 12 1A 2 1 2 3 2 4 5) 1 100 1 2 3 4 A 1 50 50 0 45mg 0 25mg 100 100 0 9mg 0 5mg A 1 4mL
untitled
-- -- -3- % % % 6% % % 9 66 95 96 35 9 6 6 9 9 5 77 6 6 5 3 9 5 9 9 55 6 5 9 5 59 () 3 5 6 7 5 7 5 5 6 6 7 77 69 39 3 6 3 7 % % % 6% % % (: ) 6 65 79 7 3 36 33 9 9 5 6 7 3 5 3 -- 3 5 6 76 7 77 3 9 6 5
untitled
NO. 2007 10 10 34 10 10 0570-058-669 http://www.i-nouryoku.com/index.html (40 ) () 1 NO. 2007 10 10 2.2 2.2 130 70 20 80 30 () () 9 10 () 78 8 9 () 2 NO. 2007 10 10 4 7 3 NO. 2007 10 10 40 20 50 2 4 NO.
Microsoft PowerPoint - 201409_秀英体の取組み素材（予稿集）.ppt
1 2 3 4 5 6 7 8 9 10 11 No Image No Image 12 13 14 15 16 17 18 19 20 21 22 23 No Image No Image No Image No Image 24 No Image No Image No Image No Image 25 No Image No Image No Image No Image 26 27 28
Microsoft Word - 月見草エキス6.1.doc
ORYZA OIL & FAT CHEMICAL CO., LTD. 月見草エキス EVENING PRIMROSE EXTRACT 抗糖尿病 ダイエット食品素材 月見草エキス -P ( 粉末 食品用途 ) 月見草エキス -WSPS ( 水溶性粉末 食品用途 ) 月見草エキス -PC ( 粉末 化粧品用途 ) 月見草エキス -LC ( 液体 化粧品用途 ) ver. 6.1 JT 抗糖尿病 ダイエット食品素材
untitled
1030, 116, 1113 1. 1030 2. 116 3. 1113 URL http://psl.fp.a.u-tokyo.ac.jp/hp/enomae/lectures/prints4lectures.htm 1. 105 1 - 10 mm 25 mm 16 1950 10, 5, 4 mm 3, 1 mm 42 200 42 (14001468) 1445 1670 1719 1798
TEL:03-5253-1111 2478 TEL:03-3595-2337 FAX:03-3503-7964 Shigella sonnei 200g 300 500cm 0.2 0.3mm 25g 0.45 m Shigella sonnei 3mL 35 37 18 ml 0.1 ml 10 10 ml 40mL 0.1 200 L 25g 1 225mL 35 37 18 24 Shigella
橡ミヤコグサ形質転換法・秋山
Page 1 2000 9 akiyama@biochem.osakafu-u.ac.jp VA 4 1999 9 2000 2 Plant J., 2, 487-496 (1992) Handberg K. and Stougaard J. Exp. Bot., 48,1357-1365 (1997) Stiller J. (Gresshoff PM) 4 80 5 10 20 ( ) < ecotype
CHEMOTHERAPY Methicillin-resistant S.aureus(MRSA) coccus epidermidis 105 Streptococcus pyogenes E.faecali senterococcus avium Enterococcus faecium Str
cefaclor(ccl),cefuroxime(cxm),cefixime (CFIX),cefteram(CFTM),cefdinir(CFDN) pneumoniae,streptococcus pyogenes Moraxella catarrhalis,haemophilus influenzae,escherichia coli, Klebsiella pneumoniae,proteus
1999年3月作成(新様式第１版)
200622 19989 871313 1mL4mg JAN oxybuprocaine hydrochloridejan 2002621 20037 4 19667 1 FAX 2005 10 29607 05 1 63 () 103 2 3 49 111 4 Drug Safety Update 1. -------------------------------------1 2. -----------------------1
平成25年度調理師試験問題
25 15 60 HB 2 1 1 2 36 1961 46 1971 56 1981 3 1991 3 4-1 - 5 6 7 8 6 2 12 31 1 15 1 15 4 15 4 15-2 - 9-3 - 10 11 12 13 3-4 - 14 腿 15 16 WHO 22 2010 17 18 1-5 - 19 1 g 4 kcal 4 kcal 9 kcal 9 kcal 20 21
CAS H 3 C C CH 2 C 9 H tert d = hpa
1 200140 35 CAS 98839 1335-2- H 3 C C CH 2 C 9 H 10 118.18 1 99 4-tert- 1. 2-23.2 2 163164 2 54 574 3 0.96.6 20 d 4 0.9082 2 4.07 = 1 2.5 hpa 1.9 mmhg20 2 4 log Pow3.48 3.44 m/z 118, 1.0 103 0.58 91 0.21
2
1 3 11 21 2 3 28 42 33 12 31 11 4 21 46.5 30.0vol 30 36 16 DXNs 46 19 B 42 22 5 0.44 10 15 20 20 1.5 1.5 0.1 0.37 6 4.5 1.7 16 1.5 1.5 4.5 1.5 7 3.6 4.4 12 8 1.5 9 46 19 19 10 500ml 11 33 3.6 3.9 12 2.1
ISO
ISO ISO ISO(International Standardization Organization) 135 ISO CD(Committee Draft) DIS(Draft for International Standard) FDIS(Final DIS) ISO ISO23500 2004.01.13 ANSI/AAMI RD52 2004.04.13 6 2004.08.09